Canada Pension Plan Investment Board Intellia Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$33.3 - $44.82 $558,474 - $751,676	16,771 Added 503.78%	20,100 $749,000
Q4 2022 Feb 14, 2023	SELL	$33.21 - $62.69 $33,210 - $62,690	-1,000 Reduced 23.1%	3,329 $116,000
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $43,136 - $57,360	800 Added 22.67%	4,329 $242,000
Q2 2022 Aug 12, 2022	SELL	$38.49 - $76.21 $26,943 - $53,346	-700 Reduced 16.55%	3,529 $183,000
Q1 2022 May 13, 2022	BUY	$58.27 - $118.99 $246,423 - $503,208	4,229 New	4,229 $307,000
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $1.41 Million - $1.94 Million	-14,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $1.85 Million - $2.47 Million	14,000 New	14,000 $1.88 Million

336

96.1M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $719M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.